List of Excipients in API elbasvir and grazoprevir
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing elbasvir and grazoprevir
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | ZEPATIER | elbasvir and grazoprevir | 0006-3074 | CARNAUBA WAX | 2031-05-04 |
| Merck Sharp & Dohme LLC | ZEPATIER | elbasvir and grazoprevir | 0006-3074 | CELLULOSE, MICROCRYSTALLINE | 2031-05-04 |
| Merck Sharp & Dohme LLC | ZEPATIER | elbasvir and grazoprevir | 0006-3074 | COPOVIDONE K25-31 | 2031-05-04 |
| Merck Sharp & Dohme LLC | ZEPATIER | elbasvir and grazoprevir | 0006-3074 | CROSCARMELLOSE SODIUM | 2031-05-04 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for elbasvir and grazoprevir
Excipient focus: CARNAUBA WAX
elbasvir and grazoprevir drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
elbasvir and grazoprevir drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
elbasvir and grazoprevir drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
elbasvir and grazoprevir drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
elbasvir and grazoprevir drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
elbasvir and grazoprevir drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
elbasvir and grazoprevir drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
elbasvir and grazoprevir drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
elbasvir and grazoprevir drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
elbasvir and grazoprevir drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
elbasvir and grazoprevir drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
elbasvir and grazoprevir drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
elbasvir and grazoprevir drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
elbasvir and grazoprevir drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
elbasvir and grazoprevir drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TOCOPHERSOLAN
elbasvir and grazoprevir drug variants containing TOCOPHERSOLAN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing TOCOPHERSOLAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
elbasvir and grazoprevir drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | elbasvir and grazoprevir | 0006-3074 |
| >Company | >Ingredient | >NDC |
elbasvir and grazoprevir drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links